Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Oct;72(4):889–895. doi: 10.1038/bjc.1995.429

Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver.

G E Arteel 1, R G Thurman 1, J M Yates 1, J A Raleigh 1
PMCID: PMC2034023  PMID: 7547236

Abstract

Nitroimidazole markers of tumour hypoxia bind to normoxic liver and the question has been raised whether this is due to low oxygen concentration or microregional activity of specialised nitroreductases. To answer this question, the binding patterns of the 2-nitroimidazole, pimonidazole, were compared following perfusion of surgically isolated rat livers in anterograde and retrograde directions. Perfusion at low flow rates in anterograde or retrograde directions can be used intentionally to alter oxygen gradients without altering enzyme distributions. Perfusion by means of the portal vein (anterograde direction) produced pimonidazole binding in the pericentral region of liver similar to that observed for pimonidazole binding in vivo. A complete reversal of this binding pattern occurred when the isolated liver was perfused by way of the central vein (retrograde direction). In this case, pimonidazole binding occurred in the periportal region. The extent and intensity of binding in the periportal region during perfusion in the retrograde direction was similar to that in the pericentral region during perfusion in the anterograde direction. It is concluded that low oxygen concentration rather than the non-homogeneous distribution of nitroreductase activity is the primary determinant of 2-nitroimidazole binding in liver.

Full text

PDF
889

Images in this article

892Figure 3
on p.892

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aw T. Y., Shan X. Q., Sillau A. H., Jones D. P. Effect of chronic hypoxia on acetaminophen metabolism in the rat. Biochem Pharmacol. 1991 Aug 8;42(5):1029–1038. doi: 10.1016/0006-2952(91)90285-d. [DOI] [PubMed] [Google Scholar]
  2. Belisario M. A., Pecce R., Della Morte R., Arena A. R., Cecinato A., Ciccioli P., Staiano N. Characterization of oxidative and reductive metabolism in vitro of nitrofluoranthenes by rat liver enzymes. Carcinogenesis. 1990 Feb;11(2):213–218. doi: 10.1093/carcin/11.2.213. [DOI] [PubMed] [Google Scholar]
  3. Bradford B. U., Marotto M., Lemasters J. J., Thurman R. G. New, simple models to evaluate zone-specific damage due to hypoxia in the perfused rat liver: time course and effect of nutritional state. J Pharmacol Exp Ther. 1986 Jan;236(1):263–268. [PubMed] [Google Scholar]
  4. Chapman J. D. Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother Oncol. 1991;20 (Suppl 1):13–19. doi: 10.1016/0167-8140(91)90181-f. [DOI] [PubMed] [Google Scholar]
  5. Cline J. M., Thrall D. E., Page R. L., Franko A. J., Raleigh J. A. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. Br J Cancer. 1990 Dec;62(6):925–931. doi: 10.1038/bjc.1990.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cline J. M., Thrall D. E., Rosner G. L., Raleigh J. A. Distribution of the hypoxia marker CCI-103F in canine tumors. Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):921–933. doi: 10.1016/0360-3016(94)90113-9. [DOI] [PubMed] [Google Scholar]
  7. Cobb L. M., Hacker T., Nolan J. NAD(P)H nitroblue tetrazolium reductase levels in apparently normoxic tissues: a histochemical study correlating enzyme activity with binding of radiolabelled misonidazole. Br J Cancer. 1990 Apr;61(4):524–529. doi: 10.1038/bjc.1990.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cobb L. M., Nolan J., Butler S. A. Distribution of pimonidazole and RSU 1069 in tumour and normal tissues. Br J Cancer. 1990 Dec;62(6):915–918. doi: 10.1038/bjc.1990.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cénas N., Anusevicius Z., Bironaité D., Bachmanova G. I., Archakov A. I., Ollinger K. The electron transfer reactions of NADPH: cytochrome P450 reductase with nonphysiological oxidants. Arch Biochem Biophys. 1994 Dec;315(2):400–406. doi: 10.1006/abbi.1994.1517. [DOI] [PubMed] [Google Scholar]
  10. Dennis M. F., Stratford M. R., Wardman P., Watts M. E. Cellular uptake of misonidazole and analogues with acidic or basic functions. Int J Radiat Biol Relat Stud Phys Chem Med. 1985 Jun;47(6):629–643. doi: 10.1080/09553008514550871. [DOI] [PubMed] [Google Scholar]
  11. Franko A. J., Koch C. J. Binding of misonidazole to V79 spheroids and fragments of Dunning rat prostatic and human colon carcinomas in vitro: diffusion of oxygen and reactive metabolites. Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1333–1336. doi: 10.1016/0360-3016(84)90343-2. [DOI] [PubMed] [Google Scholar]
  12. Franko A. J., Koch C. J., Garrecht B. M., Sharplin J., Hughes D. Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res. 1987 Oct 15;47(20):5367–5376. [PubMed] [Google Scholar]
  13. Gebhardt R., Ebert A., Bauer G. Heterogeneous expression of glutamine synthetase mRNA in rat liver parenchyma revealed by in situ hybridization and Northern blot analysis of RNA from periportal and perivenous hepatocytes. FEBS Lett. 1988 Dec 5;241(1-2):89–93. doi: 10.1016/0014-5793(88)81037-8. [DOI] [PubMed] [Google Scholar]
  14. Häussinger D., Gerok W., Sies H. The effect of urea synthesis on extracellular pH in isolated perfused rat liver. Biochem J. 1986 May 15;236(1):261–265. doi: 10.1042/bj2360261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Inman J. K. Thymus-independent antigens: the preparation of covalent, hapten-ficoll conjugates. J Immunol. 1975 Feb;114(2 Pt 1):704–709. [PubMed] [Google Scholar]
  16. Jungermann K., Katz N. Functional specialization of different hepatocyte populations. Physiol Rev. 1989 Jul;69(3):708–764. doi: 10.1152/physrev.1989.69.3.708. [DOI] [PubMed] [Google Scholar]
  17. Kashiwagi T., Lindros K. O., Ji S., Thurman R. G. Aldehyde dehydrogenase-dependent acetaldehyde metabolism in periportal and pericentral regions of the perfused rat liver. J Pharmacol Exp Ther. 1983 Mar;224(3):538–542. [PubMed] [Google Scholar]
  18. MacManus M. P., Maxwell A. P., Abram W. P., Bridges J. M. The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice. Br J Cancer. 1989 Mar;59(3):349–352. doi: 10.1038/bjc.1989.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matsumura T., Kauffman F. C., Meren H., Thurman R. G. O2 uptake in periportal and pericentral regions of liver lobule in perfused liver. Am J Physiol. 1986 Jun;250(6 Pt 1):G800–G805. doi: 10.1152/ajpgi.1986.250.6.G800. [DOI] [PubMed] [Google Scholar]
  20. Maxwell A. P., MacManus M. P., Gardiner T. A. Misonidazole binding in murine liver tissue: a marker for cellular hypoxia in vivo. Gastroenterology. 1989 Nov;97(5):1300–1303. doi: 10.1016/0016-5085(89)91703-4. [DOI] [PubMed] [Google Scholar]
  21. Mueller-Klieser W., Schlenger K. H., Walenta S., Gross M., Karbach U., Hoeckel M., Vaupel P. Pathophysiological approaches to identifying tumor hypoxia in patients. Radiother Oncol. 1991;20 (Suppl 1):21–28. doi: 10.1016/0167-8140(91)90182-g. [DOI] [PubMed] [Google Scholar]
  22. O'Dwyer P. J., Yao K. S., Ford P., Godwin A. K., Clayton M. Effects of hypoxia on detoxicating enzyme activity and expression in HT29 colon adenocarcinoma cells. Cancer Res. 1994 Jun 15;54(12):3082–3087. [PubMed] [Google Scholar]
  23. Parliament M. B., Wiebe L. I., Franko A. J. Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells. Br J Cancer. 1992 Dec;66(6):1103–1108. doi: 10.1038/bjc.1992.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Phillips R. M., de la Cruz A., Traver R. D., Gibson N. W. Increased activity and expression of NAD(P)H:quinone acceptor oxidoreductase in confluent cell cultures and within multicellular spheroids. Cancer Res. 1994 Jul 15;54(14):3766–3771. [PubMed] [Google Scholar]
  25. Raleigh J. A., Koch C. J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem Pharmacol. 1990 Dec 1;40(11):2457–2464. doi: 10.1016/0006-2952(90)90086-z. [DOI] [PubMed] [Google Scholar]
  26. Raleigh J. A., La Dine J. K., Cline J. M., Thrall D. E. An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. Br J Cancer. 1994 Jan;69(1):66–71. doi: 10.1038/bjc.1994.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Raleigh J. A., Miller G. G., Franko A. J., Koch C. J., Fuciarelli A. F., Kelly D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer. 1987 Oct;56(4):395–400. doi: 10.1038/bjc.1987.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rojas A., Joiner M. C., Hodgkiss R. J., Carl U., Kjellen E., Wilson G. D. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. Int J Radiat Oncol Biol Phys. 1992;23(2):361–366. doi: 10.1016/0360-3016(92)90754-6. [DOI] [PubMed] [Google Scholar]
  29. THOMLINSON R. H., GRAY L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955 Dec;9(4):539–549. doi: 10.1038/bjc.1955.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Thrall D. E., McEntee M. C., Cline J. M., Raleigh J. A. ELISA quantification of CCI-103F binding in canine tumors prior to and during irradiation. Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):649–659. doi: 10.1016/0360-3016(94)90190-2. [DOI] [PubMed] [Google Scholar]
  31. Thurman R. G., Kauffman F. C. Sublobular compartmentation of pharmacologic events (SCOPE): metabolic fluxes in periportal and pericentral regions of the liver lobule. Hepatology. 1985 Jan-Feb;5(1):144–151. doi: 10.1002/hep.1840050128. [DOI] [PubMed] [Google Scholar]
  32. Van Os-Corby D. J., Chapman J. D. In vitro binding of 14C-misonidazole to hepatocytes and hepatoma cells. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1251–1254. doi: 10.1016/0360-3016(86)90270-1. [DOI] [PubMed] [Google Scholar]
  33. Van Os-Corby D. J., Koch C. J., Chapman J. D. Is misonidazole binding to mouse tissues a measure of cellular pO2? Biochem Pharmacol. 1987 Oct 15;36(20):3487–3494. doi: 10.1016/0006-2952(87)90330-3. [DOI] [PubMed] [Google Scholar]
  34. Watts M. E., Dennis M. F., Roberts I. J. Radiosensitization by misonidazole, pimonidazole and azomycin and intracellular uptake in human tumour cell lines. Int J Radiat Biol. 1990 Feb;57(2):361–372. doi: 10.1080/09553009014552461. [DOI] [PubMed] [Google Scholar]
  35. Wolpert M. K., Althaus J. R., Johns D. G. Nitroreductase activity of mammalian liver aldehyde oxidase. J Pharmacol Exp Ther. 1973 May;185(2):202–213. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES